Grainger, David J., Reckless, J., Piercy, V., Langley, K., Purvis, I., Purvis, I. and Fox, David J. (2009) FX125L, a novel small molecule chemokine inhibitor, attenuates neutrophil accumulation in a model of allergic asthma and exhibits a superior efficacy profile to dexamethasone or monteleukast. In: 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Warsaw, Poland, June 06-10, 2009. Published in: Allergy, Vol.64 (Suppl. 90). p. 539. doi:10.1111/j.1398-9995.2009.02077.x ISSN 0105-4538.

Research output not available from this repository.

Request-a-Copy directly from author or use local Library Get it For Me service.

Request Changes to record.

Item Type:	Conference Item (Paper)
Subjects:	R Medicine > RA Public aspects of medicine Q Science > QR Microbiology > QR180 Immunology
Divisions:	Faculty of Science, Engineering and Medicine > Science > Chemistry
Journal or Publication Title:	Allergy
Publisher:	Wiley-Blackwell Publishing Ltd.
ISSN:	0105-4538
Official Date:	2009
Dates:	Date Event 2009 Published
Volume:	Vol.64
Number:	Suppl. 90
Number of Pages:	1
Page Range:	p. 539
DOI:	10.1111/j.1398-9995.2009.02077.x
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Conference Paper Type:	Paper
Title of Event:	28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology
Type of Event:	Conference
Location of Event:	Warsaw, Poland
Date(s) of Event:	June 06-10, 2009

Data sourced from Thomson Reuters' Web of Knowledge

Request changes or add full text files to a record

Repository staff actions (login required)

View Item